Short Interest in Procaps Group S.A. (NASDAQ:PROC) Drops By 18.4%

Procaps Group S.A. (NASDAQ:PROC) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 133,300 shares, a decrease of 18.4% from the December 31st total of 163,300 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average daily volume of 98,600 shares, the days-to-cover ratio is currently 1.4 days.

Procaps Group Trading Up 3.9 %

Shares of Procaps Group stock traded up $0.06 during trading on Thursday, hitting $1.58. 58,842 shares of the company’s stock were exchanged, compared to its average volume of 23,355. Procaps Group has a 52-week low of $0.50 and a 52-week high of $4.15. The business has a 50-day simple moving average of $1.98 and a 200-day simple moving average of $1.95.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.